Summary
- Current Price
- As of today, ALNY price is $216.98, down -1.01% on
- Current Price All-Time High
- ALNY price is currently -56.21% below its historical high of $495.55 set on
- Market Cap
- ALNY current market cap is $29B, down -49.50% year-over-year
- PE Ratio
- ALNY current PE ratio is 36.63
- Revenue
- ALNY current annual revenue is $3.71B, up +65.19% year-over-year
- Next Earnings
- The next earnings release for ALNY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Alnylam Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ALNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | alnylam.com |
| Employees | 2,230 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $216.98 | |
| Price, 1D Change | -1.01% | |
| Market Cap | $29B | |
| - | ||
| PE Ratio | 36.63 | |
| Beta | 0.29 | |
| Revenue | $3.71B | |
| Revenue, 1Y Change | +65.19% | |
| EPS | $2.33 | |
| EPS, 1Y Change | +206.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $2.33 | |
| EPS Estimate | $8.93 | N/A |
| EPS Est. Change | +283.50% | N/A |
| Revenue | $3.71B | |
| Revenue Estimate | $5.50B | N/A |
| Revenue Est. Change | +48.18% | N/A |
| Current Price | $216.98 | |
| Price Target | $353.50 | - |
| Price Tgt. Change | +62.92% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.18 | -$2.18 | -1,118.68% | |
| $4.79 | $2.33 | -51.38% | |
| $8.93 | N/A | +283.50% | |
| $12.60 | N/A | +440.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.24B | $2.25B | +0.57% | |
| $3.77B | $3.71B | -1.60% | |
| $5.50B | N/A | +48.18% | |
| $7.00B | N/A | +88.43% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -50.57% | |
| Price, 3Y | +17.27% | |
| Market Cap, 1Y | -49.50% | |
| Market Cap, 3Y | +25.63% | |
| Revenue, 1Y | +65.19% | |
| Revenue, 3Y | +258.00% | |
| EPS, 1Y | +206.91% | |
| EPS, 3Y | +125.06% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $216.98 | |
| SMA 200 | $341.55 | |
| SMA 50 | $278.68 | |
| EMA 200 | $316.86 | |
| EMA 50 | $271.33 | |
| MACD | -$19.96 | |
| Beta | 0.29 | |
| ATR | $15.22 | |
| 14-Day RSI | 33.59 | |
| 10-Day Volatility | 157.22% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $3.71B | |
| EPS | $2.33 | |
| Gross Profit | $3.03B | |
| Gross Margin | 81.64% | |
| Operating Income | $501.58M | |
| Operating Margin | 13.51% | |
| Net Income | $313.75M | |
| Net Margin | 8.45% | |
| EBITDA | $557.24M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 3.76 | |
| 2.76 | ||
| 2.71 | ||
| - | ||
| 6 | ||
| 3.93 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 36.63 | |
| 6.04 | ||
| 21.44 | ||
| 27.23 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $789.18M | |
| $2.91B | ||
| $5.03B | ||
| $4.05B | ||
| $4.24B | ||
| $1.47B | ||
| Total Debt | $2.97B | |
| $265.59M | ||
| $115.72M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $3.40B | ||
| $2.53B | ||
| $681.87M | ||
| $1.21B | ||
| $55.66M | ||
| $0.00 | ||
| $9.41M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $524.08M | ||
| $436.33M | ||
| -$305.19M | ||
| Capex | $58.70M | |
| $465.38M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Raymond James | → | |
| Citigroup | → | |
| Barclays | → | |
| Wells Fargo | → | |
| Stifel | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ALNY
FAQ
- What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
- The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY
- Does Alnylam Pharmaceuticals, Inc. pay dividends?
- No, Alnylam Pharmaceuticals, Inc. does not pay dividends
- What sector is Alnylam Pharmaceuticals, Inc. in?
- Alnylam Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Alnylam Pharmaceuticals, Inc. in?
- Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Alnylam Pharmaceuticals, Inc. based in?
- Alnylam Pharmaceuticals, Inc. is headquartered in United States
- When did Alnylam Pharmaceuticals, Inc. go public?
- Alnylam Pharmaceuticals, Inc. initial public offering (IPO) was on June 1, 2004
- Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
- No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
- Yes, Alnylam Pharmaceuticals, Inc. is included in the NASDAQ 100 index
- Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
- No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Alnylam Pharmaceuticals, Inc. last earnings report?
- Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
- When does Alnylam Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Alnylam Pharmaceuticals, Inc. is October 29, 2026
Data Sources & References
- ALNY Official Website www.alnylam.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178670/000162828026007497/0001628280-26-007497-index.htm
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- ALNY Profile on Yahoo Finance finance.yahoo.com/quote/ALNY
- ALNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alny